Stay updated with breaking news from Scientia Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
Startups feature prominently at MedCity INVEST from Pitch Perfect to Ask the Investor. Check out the investors who will be judging the startups at INVEST May 22-24 in Chicago and register today!
Can AI be the key to preventing and diagnosing illnesses? Biotech expert Harry Glorikian explains how technology can impact health and wellness for the better.
To help celebrate GEN’s 40th Anniversary with this special October issue, we asked scientists and business professionals in academia and industry to give us their reflections, impressions, and insights on the biotechnology industry and the life sciences.